Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Inhaled COVID-19 Vaccines

Global Nexus researchers are developing a next-generation, inhaled aerosol vaccine for COVID-19. This made-at-McMaster vaccine is proven to be more effective at inducing protective immune responses than traditional injections, as it targets the lungs and upper airways — where viruses first enter the body.

Meet the Researchers

Matthew Miller

Executive Director, Global Nexus & the Michael G. DeGroote Institute for Infectious Disease Research

Brian Lichty

Associate Professor, Department of Medicine and Director, Robert E. Fitzhenry Vector Lab

Fiona Smaill

Professor, Pathology and Molecular Medicine

Zhou Xing

Professor, Pathology and Molecular Medicine